Fig. 3
From: Antimicrobial resistance crisis: could artificial intelligence be the solution?
Artificial intelligence (AI) in the development of antimicrobial peptides (AMPs). AMPs databases have laid a solid foundation for AI-based model training, including natural language processing and deep generative networks. AI models can then be used to mine a wide range of protein sequence space, including the extinct human proteome, while high-throughput methods like cell-free synthesis significantly accelerate the speed of validation of candidate AMPs